Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.90 $1.74 Friday, 10th May 2024 FGEN stock ended at $1.16. This is 4.92% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.04% from a day low at $1.12 to a day high of $1.21.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Oct 21, 2016 $17.55 $17.65 $17.30 $17.40 491 400
Oct 20, 2016 $17.30 $18.06 $17.25 $17.65 453 100
Oct 19, 2016 $18.05 $18.50 $17.33 $17.35 321 500
Oct 18, 2016 $18.20 $18.65 $17.75 $17.95 327 700
Oct 17, 2016 $17.75 $18.20 $17.30 $17.75 319 900
Oct 14, 2016 $18.40 $18.50 $17.65 $17.70 230 100
Oct 13, 2016 $18.05 $18.65 $17.75 $18.15 385 300
Oct 12, 2016 $19.60 $19.95 $18.05 $18.15 483 100
Oct 11, 2016 $20.25 $20.35 $19.30 $19.55 276 900
Oct 10, 2016 $20.35 $20.80 $20.15 $20.25 291 400
Oct 07, 2016 $20.03 $20.27 $19.63 $20.03 240 800
Oct 06, 2016 $20.65 $20.85 $19.94 $20.05 245 900
Oct 05, 2016 $20.92 $20.93 $20.36 $20.73 266 200
Oct 04, 2016 $20.95 $21.10 $20.35 $20.51 372 400
Oct 03, 2016 $20.59 $20.91 $20.16 $20.80 311 700
Sep 30, 2016 $20.64 $20.92 $20.26 $20.70 470 300
Sep 29, 2016 $22.09 $22.09 $20.37 $20.42 463 600
Sep 28, 2016 $22.40 $22.62 $21.89 $22.05 296 400
Sep 27, 2016 $21.87 $22.53 $21.60 $22.46 300 900
Sep 26, 2016 $21.91 $22.12 $21.40 $21.78 287 700
Sep 23, 2016 $22.06 $22.37 $21.88 $22.16 324 600
Sep 22, 2016 $22.12 $22.18 $21.15 $22.15 331 900
Sep 21, 2016 $21.74 $21.94 $21.02 $21.83 393 200
Sep 20, 2016 $21.48 $22.20 $21.26 $21.59 620 500
Sep 19, 2016 $20.20 $21.45 $20.10 $21.30 561 900
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT